Betamethasone Dipropionate

CAS 5593-20-4 9 current records 6 historicalSmall Molecule

Who holds supplier records for Betamethasone Dipropionate? 9 organisations hold a current record for Betamethasone Dipropionate: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Spain (1), Italy (1), Malaysia (1) and 3 other countries (3); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Betamethasone Dipropionate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/betamethasone-dipropionate

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Betamethasone Dipropionate expires 19 Nov 2045. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Betamethasone Dipropionate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Betamethasone Dipropionate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Betamethasone Dipropionate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2012-079 - Rev 02
Betamethasone dipropionate, Micronised
Jun 2026Inspected Mar 2026
Germany
TARO PHARMACEUTICAL INDUSTRIES, LTD. HaifaIL
CEP 2018-018 - Rev 04
Betamethasone dipropionate, Micronised
Feb 2026Inspected Feb 2025
Israel
TAPI NL B.V. AmsterdamNL
CEP 2000-223 - Rev 09
Betamethasone dipropionate
Aug 2025—
SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. ButterworthMY
CEP 2011-005 - Rev 02
Betamethasone dipropionate
Dec 2024—
TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. TianjinCN
CEP 2022-342 - Rev 00
Betamethasone dipropionate
Apr 2024—
FARMABIOS S.p.A Gropello CairoliIT
R1-CEP 2003-232 - Rev 03
Betamethasone dipropionate, Micronised
Feb 2023—
HENAN LIHUA PHARMACEUTICAL CO., LTD. AnyangCN
R0-CEP 2020-418 - Rev 00
Betamethasone dipropionate
May 2022—
CURIA SPAIN S.A.U. BoecilloES
R1-CEP 2002-031 - Rev 03
Betamethasone dipropionate
Aug 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Betamethasone Dipropionate are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • India · Inactive DMF 22649 · filed Dec 2008
  • HOECHST MARION ROUSSEL SA
    Inactive DMF 7389 · filed Feb 1988
  • QUATRUM
    Inactive DMF 7125 · filed Aug 1987
  • United States · Inactive DMF 7095 · filed Aug 1987
  • COMPANIA ESPANOLA DE SINTESIS QUIMICA SA
    Inactive DMF 6726 · filed Nov 1986
  • Portugal · Inactive DMF 5274 · filed Mar 1984

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (28 listed products contain Betamethasone Dipropionate). The latest listed patent expires 19 Nov 2045. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Betamethasone Dipropionate is a potent synthetic glucocorticoid steroid with anti-inflammatory and immunosuppressant properties. It is commonly used in the treatment of skin conditions such as eczema, psoriasis, and dermatitis.

Chemical identity

IUPAC name
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
Canonical SMILES
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC
InChIKey
CIWBQSYVNNPZIQ-XYWKZLDCSA-N
Synonyms
Diprolene API, .beta.-methasone 17,21-dipropionate, alphatrex, betamethasone (as dipropionate), betamethasone 17,21-dipropionate, betamethasone 17.alpha.,21-dipropionate, betamethasone dipropionate, augmented, diprolene, diprosone, diprospan, maxivate, nsc-758415

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Therapeutic areas

DermatologyAllergy and ImmunologyEndocrinology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Betamethasone Dipropionate?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Betamethasone Dipropionate: CURIA SPAIN SAU (Spain), Farmabios S.p.A. (Italy), HENAN LIHUA PHARMACEUTICAL CO LTD, SYMBIOTEC PHARMALAB PRIVATE LTD (India), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (Malaysia), TAPI NL BV (Netherlands), Taro Pharmaceutical Industries Ltd. (Israel) and TIANJIN TIANYAO PHARMACEUTICALS CO LTD (China), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Betamethasone Dipropionate Drug Master Files are active?

CURIA SPAIN SAU (DMF 17046), Farmabios S.p.A. (DMF 23118), HENAN LIHUA PHARMACEUTICAL CO LTD (DMF 35853), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 25798), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (DMF 24486), TAPI NL BV (DMF 4148), Taro Pharmaceutical Industries Ltd. (DMF 14651) and TIANJIN TIANYAO PHARMACEUTICALS CO LTD (DMF 35232) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Betamethasone Dipropionate records mean?

6 organisations have only inactive Type II DMFs for Betamethasone Dipropionate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Betamethasone Dipropionate have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Betamethasone Dipropionate on the EDQM register, including SYMBIOTEC PHARMALAB LIMITED Indore (IN), TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa (IL), TAPI NL B.V. Amsterdam (NL), SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Butterworth (MY), TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin (CN) and FARMABIOS S.p.A Gropello Cairoli (IT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Betamethasone Dipropionate?

Yes. The latest patent listed for an approved US product containing Betamethasone Dipropionate expires 19 Nov 2045, across 28 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Betamethasone Dipropionate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Betamethasone Dipropionate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.